Search

everythinglearnresearchcommunity

for

Search:↓

308-nm excimer light therapy helped over a third of treatment-resistant alopecia universalis patients regrow most of their hair.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

A certain medication improved severe itching in a boy with liver and bowel disease by reducing histamine levels, suggesting a new treatment target.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Vitiligo treatment requires a personalized mix of therapies to restore skin color and improve life quality.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Chicken feather gene mutation helps understand human hair disorders.

Traditional Chinese medicine may help treat ischemic stroke by targeting specific genes and pathways.

Innate lymphoid cells help us understand and manage allergic diseases better.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Understanding different species' regeneration can improve mammalian healing.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Early diagnosis, stopping the suspected drug, and supportive care are crucial for treating Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Topical vitamin D is effective in treating vitiligo with few side effects.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Aging and chronic inflammation weaken the immune system, increasing cancer and infection risks.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.